Jim Simons Iovance Biotherapeutics, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$4.44 - $8.79 $2.25 Million - $4.45 Million
-506,300 Reduced 29.22%
1,226,400 $5.58 Million
Q2 2023

Aug 11, 2023
SELL
$5.36 - $9.06 $765,408 - $1.29 Million
-142,800 Reduced 7.61%
1,732,700 $12.2 Million
Q1 2023

May 12, 2023
SELL
$5.53 - $8.22 $7.33 Million - $10.9 Million
-1,325,400 Reduced 41.41%
1,875,500 $11.5 Million
Q4 2022

Feb 13, 2023
BUY
$5.62 - $10.0 $13.4 Million - $23.9 Million
2,392,300 Added 295.86%
3,200,900 $20.5 Million
Q3 2022

Nov 14, 2022
BUY
$9.53 - $13.11 $7.71 Million - $10.6 Million
808,600 New
808,600 $7.75 Million
Q1 2022

May 13, 2022
SELL
$12.38 - $19.1 $3.34 Million - $5.16 Million
-270,000 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$16.55 - $27.63 $4.47 Million - $7.46 Million
270,000 New
270,000 $5.15 Million
Q2 2021

Aug 13, 2021
SELL
$16.33 - $33.07 $2.3 Million - $4.65 Million
-140,600 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$28.67 - $52.59 $4.03 Million - $7.39 Million
140,600 New
140,600 $4.45 Million
Q4 2019

Feb 13, 2020
SELL
$17.95 - $29.41 $1.1 Million - $1.81 Million
-61,400 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$17.99 - $26.0 $1.1 Million - $1.6 Million
61,400 New
61,400 $1.12 Million

Others Institutions Holding IOVA

# of Institutions
313
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email